Accendra Health Hit With Second NYSE Deficiency Notice — Market Cap and Equity Below $50M
ACH sits 31% above its 52-week low of $0.191.
Summary
Accendra Health received a second NYSE continued-listing notice, this time for falling below the $50 million market cap and $50 million stockholders' equity thresholds, and has 45 days to submit a plan to regain compliance.
Key Events · Legal and Risk Events · ACH
-
Second NYSE Deficiency Notice Received
On October 27, 2026, the NYSE notified Accendra that it is out of compliance with Section 802.01B, which requires at least $50.0 million average market capitalization over 30 trading days and $50.0 million of stockholders' equity.
-
45-Day Business Plan Deadline
Within 10 business days, the company must notify the NYSE of its intent to submit a business plan, and it has 45 calendar days from receipt to file a plan showing how it will regain compliance within 18 months; acceptance brings quarterly NYSE monitoring.
-
Distinct From October Price Notice
This follows the separate NYSE notice disclosed on October 9, 2026 tied to the average closing price standard — two independent listing deficiencies now outstanding.
-
Reverse Split Vote Pending
The definitive proxy filed October 29, 2026 asks shareholders to approve a 1-for-20 to 1-for-30 reverse stock split at a December meeting, one lever aimed at the price-based deficiency.
Analysis · ACH · Trade & Services
A second, independent path to delisting risk has opened up for Accendra. On October 27, 2026, the NYSE flagged a different listing standard than the price-based notice disclosed on October 9: the company now fails the Section 802.01B requirement of at least $50.0 million average market capitalization over 30 trading days and $50.0 million in stockholders' equity. That deficiency stacks on top of the sub-$1 price problem and arrives while the company is asking shareholders to approve a 1-for-20 to 1-for-30 reverse split at a December meeting. The clock is concrete: 10 business days to tell the NYSE it will submit a plan, 45 calendar days to file a business plan showing how it regains compliance within 18 months, then quarterly NYSE monitoring if accepted. Listing is not immediately affected, but with cash of just $7.7 million as of the last 10-Q and a Q2 loss of $1.16 per share, the company has limited room to engineer a market-cap or equity cure without a capital raise or asset sales.
How filings like this one have moved
In the 30 days to Oct 30, 2026, 38.3% of the 891 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.41%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ACH was trading at $0.25 on NYSE in the Trade & Services sector, with a market capitalization of approximately $19.5M. The 52-week trading range was $0.19 to $5.24. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.